Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 12, 2004, Pages 6010-6016

  Robbins, Richard J ^a   Srivastava, Shefali ^b   Shaha, Ashok ^b   Ghossein, Ronald ^b   Larson, Steven M ^b   Fleisher, Martin ^b   Tuttle, R Michael ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN;

ADULT; AGED; BONE METASTASIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLICULAR CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN INDUCTION; RETROSPECTIVE STUDY; REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR VOLUME; UTERINE CERVIX;

ADENOCARCINOMA, FOLLICULAR; ADENOMA, OXYPHILIC; ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN;

EID: 10344243496     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031573     Document Type: Review

References (37)

1. Van Herle AJ, Uller RP, Matthews NI, Brown J 1973 Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52:1320-1327
2. Pacini F, Pinchera A, Giani C, Grasso L, Doveri F, Baschieri L 1980 Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J Endocrinol Invest 3:283-292
3. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli J, Fragu P, Lumbroso J, Caillou B, Parmentier C 1986 Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960-967
4. Torrens J, Burch J 2001 Serum thyroglobulin measurement: utility in clinical practice. Endocrinol Metab Clin North Am 30:1-34
5. Ozata M, Suzuki S, Miyamoto T, Liu R, Fierro-Renoy F, DeGroot L 1994 Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98-105
6. Pacini F, Molinaro E, Lippi F, Castagna MG, Agate L, Ceccarelli C, Taddei D, Elisei R, Capezzone M, Pinchera A 2001 Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. J Clin Endocrinol Metab 86:5686-5690
7. Robbins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM 2002 Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 87:3242-3247
8. Mazzaferri EL, Kloos RT 2002 Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 87:1490-1498
9. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668-3673
10. Haugen BR, Ridgway EC, McLaughlin BA, McDermott MT 2002 Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin. Thyroid 12:37-43
11. Wartofsky L 2002 Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic (131)1 scanning. J Clin Endocrinol Metab 87:1486-1489
12. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441
13. Matei DV, Verweij F, Scardino E, Rocco B, Renne G, Tradati N, De Cobelli O 2003 Late solitary thyroid carcinoma metastasis to the kidney: a case report. Anticancer Res 23:561-564
14. Cariou B, Charbonnel B, Heymann MF, Bridji B 2000 Cutaneous metastases from follicular thyroid cancer. Presse Med 29:1557-1558
15. Bell CD, Kovacs K, Horvath E, Smythe H, Asa S 2001 Papillary carcinoma of thyroid metastatic to the pituitary gland. Arch Pathol Lab Med 125:935-938
16. Paolini R, Toffoli S, Poletti A, Casara D, Moschino P, Fabris F, Girolami A 1997 Splenomegaly as the first manifestation of thyroid cancer metastases. Tumori 83:779-782
17. Fidler IJ 2002 The organ microenvironment and cancer metastasis. Differentiation 70:498-505
18. Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G 2002 Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. J Endocrinol Invest 25:110-115
19. Girelli ME, Busnardo B, Amerio R, Scotton G, Casara D, Betterle C, Piccolo M, Pelizzo MR 1985 Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppression therapy: study on 429 patients. Eur J Nucl Med 10:252-254
20. Tickoo SK, Pittas AG, Adler M, Fazzari M, Larson SM, Robbins RJ, Rosai J 2000 Bone metastases from thyroid carcinoma. Arch Pathol Lab Med 124: 1440-1447
21. Robbins RJ, Larson SM, Sinha N, Shaha A, Divgi C, Pentlow KS, Ghossein R, Tuttle RM 2002 A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation. J Nucl Med 43:1482-1488
22. Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD 2001 Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 86:619-625
23. Feldt-Rasmussen U, Profilis C, Colinet E, Black E, Bornet H, Bourdoux P, Carayon P, Ericsson UB, Koutras DA, Lamas de Leon L, DeNayer P, Pacini F, Palumbo G, Santos A, Schlumberger M, Seidel C, Van Herle AJ, De Vijlder JJ 1996 Human thyroglobulin reference material (CRM 457). I. Assessment of homogeneity, stability and immunoreactivity. Ann Biol Clin (Paris) 54:337-342
24. Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ 2000 Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 10:261-268
25. Ain K 1995 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 24:711-760
26. Grebe SK, Hay ID 1995 Follicular thyroid cancer. Endocrinol Metab Clin North Am 24:761-801
27. Schlumberger M 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
28. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH 2001 Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 86:1660-1664
29. 131I activities versus untreated patients. J Clin Endocrinol Metab 86:4092-4097
30. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111
31. Bachelot A, Cailleux A, Klain M, Baudin E, Ricard M, Bellon N, Caillou B, Travagli J, Schlumberger M 2002 Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 12:707-712
32. Dralle H, Schwarzrock R, Lang W, Bocker W, Ziegler H, Schroder S, Geerlings H 1985 Comparison of histology and immunohistochemistry with thyroglobulin serum levels and radioiodine uptake in recurrences and metastases of differentiated thyroid carcinomas. Acta Endocrinol (Copenh) 108:504-510
33. Shah DH, Dandekar SR, Jeevanram RK, Kumar A, Sharma SM, Ganatra RD 1981 Serum thyroglobulin differentiated thyroid carcinoma: histological and metastatic classification. Acta Endocrinol (Copenh) 98:222-226
34. Schlumberger M, Challeton C, De Vathaire F, Travagli J, Gardet P, Lumbroso J, Francese C, Fontaine F, Ricard M, Parmentier C 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605
35. Bednar J, Nemec J, Zamrazil V, Vana S, Pohunkova D, Rohling S1983 Serum thyroglobulin determinations in patients with differentiated thyroid carcinoma. Nuklearmedizin 22:204-211
36. Giovanni V, Arianna LG, Antonio C, Francesco F, Michele K, Giovanni S, Marco S, Giovanni L 2002 The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: experience from a large patient cohort in a single centre. Clin Endocrinol (Oxf) 56:247-252
37. - symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-3234